초록 ▼

A novel gene 251P5G2 and its encoded protein, and variants thereof, are described wherein 251P5G2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 251P5G2 provides a diagnostic, prognostic, prophylactic and/or the

A novel gene 251P5G2 and its encoded protein, and variants thereof, are described wherein 251P5G2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 251P5G2 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 251P5G2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 251P5G2 can be used in active or passive immunization.

대표청구항 ▼

The invention claimed is: 1. An isolated polynucleotide which has the nucleic acid sequence of SEQ ID NO:2. 2. An isolated polynucleotide which has the nucleic acid sequence comprising residues 722 to 1489 of SEQ ID NO:2. 3. A viral vector that comprises the polynucleotide of claim 1. 4. An i

The invention claimed is: 1. An isolated polynucleotide which has the nucleic acid sequence of SEQ ID NO:2. 2. An isolated polynucleotide which has the nucleic acid sequence comprising residues 722 to 1489 of SEQ ID NO:2. 3. A viral vector that comprises the polynucleotide of claim 1. 4. An isolated host cell that contains the vector of claim 3. 5. A process for producing a protein comprising the amino acid sequence of SEQ ID NO:3, comprising culturing a host cell of claim 4 under conditions sufficient for the production of the protein, and recovering the protein from the culture.